Revista Peruana de Ginecologia y Obstetricia is a prominent academic journal dedicated to advancing research and clinical practice in the field of obstetrics and gynecology. Published by the SOC PERUANA OBSTETRICIA & GINECOLOGIA, this journal serves as a vital resource for researchers, practitioners, and students in Peru and beyond. With the ISSN 2304-5124 and E-ISSN 2304-5132, it offers insights into contemporary issues, innovative practices, and scientific breakthroughs within the discipline. Although currently categorized in Q4 of the Obstetrics and Gynecology category and ranked 176/209 in Scopus, the journal is committed to increasing its impact factor and scholarly influence by providing a platform for high-quality research. With access options that enhance its visibility and reach, the journal aims to promote knowledge sharing and collaboration among professionals in the field. Operating from its Lima base, the Revista Peruana de Ginecologia y Obstetricia is an essential publication for anyone involved in women's health and related medical research.

Ginekologia Polska is a distinguished journal in the field of Obstetrics and Gynecology, published by VIA MEDICA. Established in 1948, and with an Open Access model adopted since 2007, this journal aims to disseminate high-quality research and advancements in women's health. With an ISSN of 0017-0011 and an E-ISSN of 2543-6767, it has been indexed in major databases, reflecting its relevance in the medical community, currently holding a Q3 category in the latest 2023 rankings. Hailing from Poland, the journal serves as a vital platform for researchers, practitioners, and students to engage with contemporary issues and innovations in gynecological and obstetric care, making significant contributions to both local and global health discussions. It is essential reading for those committed to advancing their understanding and practice in this critical field.

Obstetrical & Gynecological Survey, a leading journal in the fields of obstetrics and gynecology, is published by Lippincott Williams & Wilkins. With a history dating back to 1946, this esteemed journal provides a comprehensive platform for raising awareness and fostering advances in the health and clinical practices surrounding women's reproductive health. Its current rankings highlight its significance, placing it in the Q2 category for Obstetrics and Gynecology and Q3 for Medicine (miscellaneous) in 2023, with a Scopus rank of 105 out of 209. The journal aims to deliver high-quality, peer-reviewed articles on a diverse range of topics, including clinical studies, reviews, and innovative research, making it an essential resource for researchers, practitioners, and students in the field. Though it does not currently offer open access, the journal's impactful contributions continue to shape the dialogue and advancements within the specialty.

Clinical and Experimental Obstetrics & Gynecology is a prominent journal published by IMR PRESS, dedicated to the fields of obstetrics, gynecology, and reproductive medicine. Since its establishment in 1974, this journal has been a crucial platform for the dissemination of research findings, innovative practices, and reviews that contribute to the advancement of women's health. With an Open Access model adopted in 2019, it ensures that high-quality research is accessible to all stakeholders in the field, thus promoting greater collaboration and knowledge sharing. Based in Hong Kong, the journal is indexed under various categories with a 2023 Quartile ranking of Q3 in Obstetrics and Gynecology and Q4 in Reproductive Medicine, affirming its role in shaping the academic conversation within these disciplines. Despite its current Scopus rankings placing it in the lower percentiles, the journal continues to grow in influence, making it an essential resource for researchers, healthcare professionals, and students aiming to stay at the forefront of clinical and experimental innovations in obstetrics and gynecology.

HYPERTENSION IN PREGNANCY is a leading academic journal dedicated to the critical study of hypertensive disorders during pregnancy, a crucial area of maternal and fetal health. Published by Taylor & Francis Inc, this journal boasts an Open Access policy since 2023, ensuring that research findings are freely accessible to a global audience. With an ISSN of 1064-1955 and E-ISSN of 1525-6065, it offers a platform for high-quality research and review articles since its inception in 1982. The journal holds a Q3 category ranking in both Internal Medicine and Obstetrics and Gynecology, reflecting its reputable standing within the scientific community. As of 2023, it ranks among the top quartile publications in its field, with Scopus ranking it 86/209 in Obstetrics and Gynecology and 83/167 in Internal Medicine. This journal aims to foster dialogue among researchers, clinicians, and policymakers regarding the management and implications of hypertension in pregnancy, promoting advancements in care and research methodologies. Located in Philadelphia, PA, it continues to be an invaluable resource for those invested in improving maternal health outcomes and advancing the field.

The Journal of Gynecology Obstetrics and Human Reproduction, published by Elsevier Masson, is an esteemed platform dedicated to advancing knowledge in the fields of gynecology, obstetrics, and reproductive medicine. Established in 2016, this journal has quickly gained prominence, currently holding a Q2 ranking in both Obstetrics and Gynecology, as well as Reproductive Medicine, as of 2023. With its base in France, the journal aims to provide crucial insights and the latest research findings, catering to a diverse audience of researchers, professionals, and students. The journal operates under the open access model, ensuring that high-quality articles are freely accessible, fostering collaboration and knowledge exchange among practitioners and scholars. With a broad scope covering various facets of women's health, the Journal of Gynecology Obstetrics and Human Reproduction is committed to contributing to the advancement of research and practice in these vital fields.

Fetal and Pediatric Pathology, an esteemed journal published by TAYLOR & FRANCIS INC, is dedicated to advancing the field of pediatric and fetal medicine through the dissemination of high-quality research and clinical insights. With an ISSN of 1551-3815 and an E-ISSN of 1551-3823, the journal has been a key resource for researchers and practitioners since its inception in 1983. Based in the United Kingdom, it covers a broad spectrum of topics relevant to Medicine, Pathology and Forensic Medicine, and Pediatrics, Perinatology, and Child Health, consistently reflecting on contemporary challenges faced in these fields. The journal has attained a commendable Q3 ranking within its categories as of 2023, underlining its relevance in the academic community. Though not an open-access publication, the research presented in Fetal and Pediatric Pathology plays a pivotal role in informing practice, guiding future studies, and enhancing the understanding of diseases affecting fetuses and children. Its convergence of research throughout multiple years, continuing until 2024, marks it as a crucial platform for ongoing scientific dialogue and innovation, aimed at fostering better health outcomes for younger populations.

European Journal of Obstetrics & Gynecology and Reproductive Biology-X, published by ELSEVIER, serves as a pivotal platform in the fields of obstetrics, gynecology, and reproductive biology. With an ISSN of 2590-1613, this journal has developed a notable presence since its transition to Open Access in 2019, enabling wider dissemination of research findings and fostering collaboration across disciplines. Located in Amsterdam, Netherlands, this journal holds a commendable Q2 ranking in both Obstetrics and Gynecology and Reproductive Medicine categories for 2023, reflecting its impact and relevance in the scientific community. Researchers and practitioners can access cutting-edge studies and reviews, contributing to advancements in reproductive health and clinical practices. With a focus on innovative research and evidence-based practices, the European Journal of Obstetrics & Gynecology and Reproductive Biology-X is committed to bridging the gap between laboratory discoveries and the application in clinical settings, making it an essential resource for those dedicated to enhancing reproductive health outcomes.

Maternal-Fetal Medicine is a pivotal open-access journal dedicated to advancing the field of reproductive health, encompassing both obstetrics and pediatrics. Published by Lippincott Williams & Wilkins, this journal has been providing a platform for groundbreaking research and comprehensive reviews since its transition to open access in 2019. With an ISSN of 2096-6954 and E-ISSN 2641-5895, it aims to disseminate high-quality findings that inform clinical practice and improve maternal and child health outcomes. The journal operates within the United States and is strategically positioned in Q3 of both the Obstetrics and Gynecology and Pediatrics, Perinatology and Child Health categories according to the 2023 evaluation metrics. Despite its relatively recent establishment, Maternal-Fetal Medicine is committed to addressing essential issues and innovations in maternal-fetal health, fostering a collaborative environment for researchers, clinicians, and educators. It serves as a vital resource for those committed to pushing the boundaries of knowledge in this critical area of healthcare.

Obstetric Medicine is a prominent journal published by SAGE Publications Ltd that focuses on advancing the field of obstetrics and gynecology through innovative research and clinical insights. With an ISSN of 1753-495X and an E-ISSN of 1753-4968, the journal has established itself as an essential resource for practitioners, researchers, and students alike, particularly noted for its contributions to maternal health and pregnancy-related conditions. Operating from the United Kingdom, the journal is indexed in Scopus and is currently ranked within the 42nd percentile in its category, reflecting its commitment to high-quality scholarship. Although it is categorized in the Q3 quartile for 2023, Obstetric Medicine continues to evolve as its scope widens, appealing to a diverse audience interested in both clinical and research aspects of obstetric care. The journal fosters a rich platform for exchanging ideas and findings, enabling readers to stay abreast of the latest advancements and practices in the field. Engaging with this journal provides valuable insights that can enhance the knowledge base and clinical skills of those dedicated to women’s health.